|
Sun Pharma Advanced Research Company Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
4564.72 Cr.
|
P/BV
|
-58.99
|
Book Value (Rs.)
|
-2.38
|
|
52 Week High/Low (Rs.)
|
258/109
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2020
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 29.67 | 30.42 | 45.13 |
| Total Income From Operations | 29.67 | 30.42 | 45.13 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 12.84 | 16.49 | 11.64 |
| Employees Cost | 92.74 | 80.01 | 61.83 |
| Depreciation | 6.30 | 6.23 | 6.28 |
| Other Expenses | 120.36 | 142.37 | 165.31 |
| Total Expenses | 232.24 | 245.10 | 245.06 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -202.57 | -214.68 | -199.93 |
| Other Income | 1.60 | 10.79 | 18.68 |
| P/L Before Interest, Excpt. Items & Tax | -200.97 | -203.89 | -181.25 |
| Interest | 1.70 | 1.17 | 0.52 |
| P/L Before Exceptional Items & Tax | -202.67 | -205.06 | -181.77 |
| P/L Before Tax | -202.67 | -205.06 | -181.77 |
| Tax | 0.56 | 0.38 | 0.00 |
| P/L After Tax from Ordinary Activities | -203.23 | -205.44 | -181.77 |
| Net Profit/Loss For the Period | -203.23 | -205.44 | -181.77 |
| Net P/L After Minority Interest & Share Of Associates | -203.23 | -205.44 | -181.77 |
| | | | |
| Equity Share Capital | 32.45 | 32.45 | 32.45 |
| Reserves And Surplus | 0.00 | 480.32 | 0.00 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | -6.26 | -6.33 | -5.60 |
| Diluted EPS (Rs.) | -6.26 | (6.33) | -5.60 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | -6.26 | -6.33 | -5.60 |
| Diluted EPS (Rs.) | -6.26 | (6.33) | -5.60 |
| | | | |
| PBITOE Margin (%) | -682.74 | -705.71 | -443.00 |
| PBTE Margin (%) | -683.08 | -674.09 | -402.76 |
| PBT Margin (%) | -683.08 | -674.09 | -402.76 |
| PAT Margin (%) | -684.96 | -675.34 | -402.76 |
| PAT After MI And SOA Margin (%) | -684.96 | -675.34 | -402.76 |
